Total Payments
$2,166
2024 Payments
$561.63
Companies
26
Transactions
117
Medicare Patients
4,005
Medicare Billing
$382,562
Payment Breakdown by Category
Food & Beverage$2,166 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,166 | 117 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $486.88 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $280.89 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $267.03 | 17 | $0 (2024) |
| ABBVIE INC. | $212.76 | 9 | $0 (2024) |
| Abbott Laboratories | $179.27 | 11 | $0 (2024) |
| Amgen Inc. | $169.84 | 10 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $60.70 | 4 | $0 (2021) |
| PFIZER INC. | $56.56 | 3 | $0 (2024) |
| Dexcom, Inc. | $47.91 | 3 | $0 (2023) |
| Dynavax Technologies Corporation | $45.15 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $561.63 | 24 | GlaxoSmithKline, LLC. ($175.35) |
| 2023 | $391.25 | 24 | Novo Nordisk Inc ($152.92) |
| 2022 | $285.19 | 16 | Novo Nordisk Inc ($70.55) |
| 2021 | $291.78 | 12 | Novo Nordisk Inc ($170.78) |
| 2020 | $75.39 | 5 | Currax Pharmaceuticals LLC ($29.00) |
| 2019 | $159.56 | 10 | Amgen Inc. ($105.04) |
| 2018 | $195.27 | 13 | Astellas Pharma US Inc ($77.88) |
| 2017 | $205.60 | 13 | Astellas Pharma US Inc ($108.17) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $108.13 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: PAIN | ||||||
| 08/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.23 | General |
| 07/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes Care | ||||||
| 06/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, AREXVY | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: VACCINES | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 05/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/29/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Hepatitis B Vaccine | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Biological | ||||||
| 04/22/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: VACCINES | ||||||
| 04/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: PAIN | ||||||
| 04/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes Care | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 02/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX, FLULAVAL QUADRIVALENT | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.27 | General |
| Category: NEUROSCIENCE | ||||||
| 12/21/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,011 | 1,243 | $297,800 | $104,222 |
| 2022 | 15 | 1,072 | 1,243 | $250,238 | $103,740 |
| 2021 | 20 | 1,031 | 1,336 | $208,113 | $94,963 |
| 2020 | 16 | 891 | 1,156 | $199,368 | $79,638 |
Total Patients
4,005
Total Services
4,978
Medicare Billing
$382,562
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 282 | 448 | $126,302 | $38,315 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 256 | 256 | $100,096 | $33,393 | 33.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 38 | 38 | $17,252 | $10,687 | 61.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 106 | 108 | $13,810 | $7,735 | 56.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 35 | $13,618 | $4,762 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 109 | 111 | $6,650 | $3,388 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 39 | $7,733 | $2,362 | 30.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 38 | $2,014 | $1,160 | 57.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 23 | $4,305 | $972.58 | 22.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 19 | 19 | $2,470 | $925.16 | 37.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 42 | 42 | $2,436 | $327.32 | 13.4% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 13 | 13 | $637.00 | $116.90 | 18.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 57 | $285.00 | $43.30 | 15.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 16 | $192.00 | $35.20 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 295 | 444 | $102,225 | $34,598 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 208 | 208 | $62,152 | $27,448 | 44.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 34 | 34 | $15,436 | $9,454 | 61.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 102 | 102 | $14,952 | $6,965 | 46.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 35 | $11,133 | $4,714 | 42.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 73 | $11,075 | $3,981 | 35.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 14 | 14 | $5,390 | $3,484 | 64.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 102 | 102 | $5,921 | $3,003 | 50.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 20 | 20 | $2,900 | $2,663 | 91.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 61 | 61 | $6,381 | $2,282 | 35.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 66 | 66 | $3,455 | $1,955 | 56.6% |
About Dr. James Hornsby, MD
Dr. James Hornsby, MD is a Family Medicine healthcare provider based in Kennesaw, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992701007.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Hornsby, MD has received a total of $2,166 in payments from pharmaceutical and medical device companies, with $561.63 received in 2024. These payments were reported across 117 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,166).
As a Medicare-enrolled provider, Hornsby has provided services to 4,005 Medicare beneficiaries, totaling 4,978 services with total Medicare billing of $382,562. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Kennesaw, GA
- Active Since 06/23/2005
- Last Updated 03/07/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1992701007
Products in Payments
- VRAYLAR (Drug) $200.50
- AREXVY (Drug) $164.25
- MYRBETRIQ (Drug) $142.18
- RYBELSUS (Drug) $125.00
- Ozempic (Drug) $118.12
- Rybelsus (Drug) $110.05
- Myrbetriq (Drug) $108.17
- Aimovig (Biological) $99.05
- NURTEC ODT (Drug) $99.00
- SHINGRIX (Biological) $92.48
- FREESTYLE LIBRE 3 (Device) $73.80
- EVENITY (Biological) $58.84
- CONTRAVE (Drug) $58.56
- XIFAXAN (Drug) $52.42
- Dexcom G6 Transmitter (Medical Supply) $47.91
- Heplisav-B (Drug) $45.15
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $43.86
- MOUNJARO (Drug) $35.08
- SUNOSI (Drug) $25.99
- XARELTO (Drug) $25.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kennesaw
Emem Udo, Md, MD
Family Medicine — Payments: $6,215
Family Medicine $6,215
Dr. Daniel Kuzio, M.d, M.D
Family Medicine — Payments: $4,856
Family Medicine $4,856
Emma Atherton-Staples, D.o, D.O
Family Medicine — Payments: $3,789
Family Medicine $3,789
Dr. Joseph Boecker, D.o, D.O
Family Medicine — Payments: $3,227
Family Medicine $3,227
Dr. John Douglas, M.d, M.D
Family Medicine — Payments: $2,653
Family Medicine $2,653
Kashondra Harris, Fnp, FNP
Family Medicine — Payments: $941.77
Family Medicine $941.77